Ligand Pharmac-B
LGND288.0102.79% ( -8.270 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Ligand Pharmac-B(LGND) predict that the Revenue is 51.72 M (+14.09%), Miss estimate;the EBIT is 17.37 M (+148%), Miss estimate;the EPS is -0.67 (+69.68%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.05B14.09%
0.06B29.84%
-0.01B15.75%
EBITMiss expectations
0.02B147.96%
0.02B150.71%
-0.00B2.75%
EPSMiss expectations
-0.6769.68%
0.9783144.27%
-1.648374.59%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 6, 2026
Estimate Revenue61.74 M
Estimate EBIT27.82 M
Estimate EPS1.1487
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf